Physician
University of Texas Health Science Center at San Antonio
University of Texas Health Science Center at San Antonio was paid $35.44M by Medicaid between Jan 2018 and Dec 2024, across 390 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 18% of everything it billed.
33Billing provider infoUNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO
SAN ANTONIO, TX 78229
SAN ANTONIO, TX 78229
33aNPI1720051717assigned 02/09/2006
33bProvider typeAnesthesiology Physician
28Total paid$35.44M
24GClaims909,986
24DCodes billed390
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in Texas
Rank by total paid#2 of 134
Median peer was paid$34K
This provider vs. median1,043×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,460 | $166K | |
| 2019 | 17,046 | $140K | |
| 2020 | 49,510 | $1.38M | |
| 2021 | 239,961 | $8.16M | |
| 2022 | 248,646 | $10.18M | |
| 2023 | 202,175 | $10.11M | |
| 2024incomplete | 135,188 | $5.30M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 100,950 | 96,452 | $6.31M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.4% | 74,684 | 68,533 | $3.33M |
| H2022 | Community-based wrap-around services, per diem | 9.2% | 2,529 | 1,511 | $3.25M |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 3.8% | 2,296 | 2,144 | $1.35M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.2% | 15,381 | 14,010 | $1.15M |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | 2.9% | 3,766 | 3,586 | $1.04M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.9% | 18,661 | 17,834 | $1.03M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.5% | 8,984 | 8,486 | $880K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.2% | 19,301 | 18,168 | $788K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.9% | 8,634 | 8,248 | $684K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.9% | 5,678 | 5,469 | $663K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.8% | 11,666 | 11,249 | $632K |
378 more codes
| 99460 | 1.7% | 7,189 | $596K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.7% | 9,499 | $593K |
| 99238 | Hospital discharge day management, 30 minutes or less | 1.6% | 9,476 | $584K |
| 99285 | Emergency room visit (most serious) | 1.6% | 6,444 | $572K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1.6% | 5,378 | $553K |
| 99203 | Doctor's office visit, new patient (routine) | 1.4% | 6,614 | $500K |
| 99232 | Hospital visit by a doctor, follow-up day | 1.3% | 9,798 | $443K |
| 76819 | Fetal biophysical profile; without non-stress testing | 1.0% | 10,586 | $371K |
| 71045 | Radiologic examination, chest; single view | 1.0% | 60,853 | $369K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 4,017 | $350K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 13,258 | $348K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 2,721 | $346K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 4,101 | $342K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 3,742 | $342K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 3,280 | $323K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,858 | $297K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 6,762 | $296K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 5,066 | $293K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 6,499 | $292K |
| 88307 | <1% | 3,618 | $244K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 2,927 | $240K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 3,900 | $229K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,073 | $169K |
| 74018 | <1% | 25,060 | $167K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,673 | $163K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 1,194 | $162K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,932 | $150K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 13,930 | $145K |
| 99205 | Prolong outpt/office vis | <1% | 870 | $142K |
| 93320 | <1% | 5,576 | $141K | |
| 80053 | Comprehensive metabolic panel | <1% | 24,525 | $132K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,202 | $124K |
| 77014 | <1% | 1,367 | $116K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 653 | $113K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,551 | $108K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 11,243 | $103K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,125 | $102K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,475 | $98K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,863 | $93K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 22,376 | $93K |
| 99462 | <1% | 2,195 | $89K | |
| 76801 | <1% | 2,065 | $88K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 43 | $86K |
| 80050 | General health panel | <1% | 2,324 | $85K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 1,293 | $84K |
| 92015 | Determination of refractive state | <1% | 5,106 | $82K |
| 76770 | <1% | 2,111 | $79K | |
| 76830 | Ultrasound, transvaginal | <1% | 2,752 | $71K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,543 | $71K |
| 59514 | <1% | 115 | $70K | |
| 93000 | <1% | 5,204 | $69K | |
| 92134 | <1% | 2,908 | $63K | |
| 93325 | <1% | 7,393 | $61K | |
| 0002A | <1% | 3,496 | $57K | |
| 01961 | <1% | 166 | $55K | |
| 72082 | <1% | 1,259 | $49K | |
| 95782 | <1% | 466 | $49K | |
| 0001A | <1% | 3,827 | $47K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,149 | $47K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 2,101 | $46K |
| 71250 | <1% | 864 | $46K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,459 | $44K |
| 69210 | <1% | 1,719 | $44K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 494 | $44K |
| 73130 | <1% | 2,810 | $42K | |
| 64643 | <1% | 350 | $40K | |
| 99334 | <1% | 998 | $40K | |
| 73630 | <1% | 3,614 | $40K | |
| 76506 | <1% | 2,646 | $40K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,868 | $39K |
| 99381 | <1% | 424 | $38K | |
| 73562 | <1% | 2,044 | $38K | |
| 99349 | <1% | 438 | $38K | |
| 95812 | <1% | 203 | $37K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,006 | $35K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 607 | $34K |
| 99243 | <1% | 354 | $34K | |
| 76642 | <1% | 1,220 | $30K | |
| 80061 | Lipid panel | <1% | 4,324 | $30K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 963 | $29K |
| 73610 | <1% | 2,035 | $27K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,011 | $27K |
| 88141 | <1% | 1,409 | $27K | |
| 73110 | <1% | 1,305 | $26K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,202 | $26K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 108 | $26K |
| 85027 | <1% | 8,519 | $25K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 215 | $24K |
| 64642 | <1% | 254 | $23K | |
| 76010 | <1% | 3,092 | $22K | |
| 99348 | <1% | 423 | $22K | |
| 76825 | <1% | 198 | $22K | |
| 76820 | <1% | 997 | $21K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,179 | $20K |
| 54150 | <1% | 239 | $20K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 536 | $20K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 338 | $20K |
| 90461 | <1% | 3,818 | $20K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,278 | $19K |
| 82728 | <1% | 2,149 | $17K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 156 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,110 | $16K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,080 | $16K |
| 51728 | <1% | 82 | $16K | |
| 86077 | <1% | 478 | $16K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 522 | $16K |
| 82378 | <1% | 1,181 | $16K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 104 | $15K |
| 95720 | <1% | 102 | $15K | |
| 94375 | <1% | 993 | $14K | |
| 99242 | <1% | 191 | $14K | |
| 77066 | Tomosynthesis, mammo | <1% | 382 | $14K |
| 83735 | <1% | 4,956 | $14K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 243 | $13K |
| 73030 | <1% | 972 | $13K | |
| 94726 | <1% | 1,510 | $13K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,054 | $13K |
| 76813 | <1% | 206 | $12K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 731 | $12K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 731 | $12K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,122 | $12K |
| 99223 | Prolong inpt eval add15 m | <1% | 100 | $11K |
| 94060 | <1% | 1,363 | $11K | |
| 83615 | <1% | 3,328 | $11K | |
| 31575 | <1% | 236 | $11K | |
| 99157 | <1% | 94 | $11K | |
| 99347 | <1% | 261 | $11K | |
| 11721 | <1% | 963 | $10K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 279 | $10K |
| 84439 | <1% | 1,883 | $10K | |
| 0071A | <1% | 261 | $10K | |
| 83550 | <1% | 1,873 | $10K | |
| 0072A | <1% | 252 | $10K | |
| 99245 | <1% | 53 | $9K | |
| 20610 | <1% | 267 | $9K | |
| 94729 | <1% | 1,388 | $9K | |
| 85610 | <1% | 4,046 | $9K | |
| 82607 | <1% | 1,258 | $9K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 194 | $9K |
| 85730 | <1% | 2,350 | $8K | |
| 74183 | <1% | 66 | $8K | |
| 73502 | <1% | 345 | $8K | |
| 99255 | <1% | 43 | $8K | |
| 92083 | <1% | 314 | $8K | |
| 49083 | <1% | 112 | $8K | |
| 76942 | <1% | 417 | $8K | |
| 83540 | <1% | 2,031 | $7K | |
| 84100 | <1% | 3,725 | $7K | |
| 17110 | <1% | 81 | $7K | |
| 87340 | <1% | 1,130 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 314 | $7K |
| 99152 | <1% | 1,041 | $7K | |
| 64644 | <1% | 99 | $7K | |
| 59025 | Fetal non-stress test | <1% | 271 | $7K |
| 81001 | <1% | 5,071 | $7K | |
| 73590 | <1% | 612 | $7K | |
| 76827 | <1% | 198 | $7K | |
| 82746 | <1% | 868 | $6K | |
| 51797 | <1% | 68 | $6K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 60 | $6K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 106 | $6K |
| 90961 | <1% | 250 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,499 | $6K |
| 93970 | <1% | 246 | $6K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 94 | $6K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 679 | $6K |
| 86803 | <1% | 601 | $6K | |
| 85007 | <1% | 2,438 | $6K | |
| 51798 | <1% | 1,010 | $6K | |
| 88342 | <1% | 203 | $6K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 68 | $6K |
| 73560 | <1% | 691 | $5K | |
| 73552 | <1% | 377 | $5K | |
| 73080 | <1% | 243 | $5K | |
| 77072 | <1% | 631 | $5K | |
| 54161 | <1% | 40 | $5K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 229 | $5K |
| 94618 | <1% | 306 | $5K | |
| 93304 | <1% | 95 | $5K | |
| 99253 | <1% | 52 | $5K | |
| 95816 | <1% | 120 | $5K | |
| 78306 | <1% | 27 | $5K | |
| 93922 | <1% | 404 | $4K | |
| 01968 | <1% | 25 | $4K | |
| 73090 | <1% | 343 | $4K | |
| 93227 | <1% | 311 | $4K | |
| 92133 | <1% | 139 | $4K | |
| 82105 | <1% | 553 | $4K | |
| 72100 | <1% | 411 | $4K | |
| 76536 | <1% | 156 | $4K | |
| 99254 | <1% | 28 | $4K | |
| 81003 | <1% | 4,310 | $4K | |
| 82248 | <1% | 1,538 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 225 | $3K |
| 77065 | Tomosynthesis, mammo | <1% | 116 | $3K |
| 92504 | <1% | 619 | $3K | |
| 30802 | <1% | 44 | $3K | |
| 54160 | <1% | 27 | $3K | |
| 80074 | <1% | 87 | $3K | |
| 85390 | <1% | 602 | $3K | |
| 85652 | <1% | 1,994 | $3K | |
| 95811 | <1% | 26 | $3K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 38 | $3K |
| 84550 | <1% | 957 | $3K | |
| 20552 | <1% | 97 | $3K | |
| 87807 | <1% | 211 | $3K | |
| 80076 | <1% | 488 | $3K | |
| 73564 | <1% | 78 | $2K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 36 | $2K |
| 83020 | <1% | 407 | $2K | |
| 95886 | <1% | 14 | $2K | |
| 93975 | <1% | 51 | $2K | |
| 95874 | <1% | 185 | $2K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 221 | $2K |
| 74178 | <1% | 12 | $2K | |
| 99335 | <1% | 34 | $2K | |
| 80503 | <1% | 132 | $2K | |
| 73521 | <1% | 130 | $2K | |
| 51784 | <1% | 87 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,192 | $2K |
| 94010 | <1% | 271 | $2K | |
| 31622 | <1% | 29 | $2K | |
| 88112 | <1% | 98 | $2K | |
| 95813 | <1% | 25 | $2K | |
| 88341 | <1% | 15 | $2K | |
| 99384 | <1% | 13 | $2K | |
| 72157 | <1% | 12 | $2K | |
| 86850 | <1% | 927 | $2K | |
| 90837 | Psychotherapy session, about an hour | <1% | 21 | $1K |
| 96367 | <1% | 54 | $1K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 165 | $1K |
| 88350 | <1% | 29 | $1K | |
| 82950 | <1% | 382 | $1K | |
| 0004A | <1% | 84 | $1K | |
| 88302 | <1% | 203 | $1K | |
| 77073 | <1% | 55 | $1K | |
| 30801 | <1% | 23 | $1K | |
| 70486 | <1% | 38 | $1K | |
| 84153 | <1% | 152 | $1K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 25 | $1K |
| 86704 | <1% | 133 | $1K | |
| 96160 | <1% | 422 | $1K | |
| 72170 | <1% | 61 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 70 | $1K |
| 59430 | <1% | 12 | $1K | |
| 0124A | <1% | 44 | $1K | |
| 90836 | <1% | 17 | $1K | |
| 99155 | <1% | 14 | $1K | |
| 85576 | <1% | 262 | $984.43 | |
| 99382 | <1% | 12 | $938.57 | |
| 82550 | <1% | 256 | $899.23 | |
| 74455 | <1% | 13 | $887.58 | |
| 87428 | <1% | 25 | $865.70 | |
| 84703 | <1% | 1,094 | $857.39 | |
| 99156 | <1% | 13 | $847.44 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 761 | $832.79 |
| 93321 | <1% | 94 | $820.42 | |
| 99221 | <1% | 14 | $815.99 | |
| 0111A | <1% | 20 | $800.00 | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 17 | $796.67 |
| 72141 | <1% | 14 | $769.10 | |
| 95117 | <1% | 91 | $742.99 | |
| 83690 | <1% | 328 | $741.47 | |
| 96417 | <1% | 14 | $695.39 | |
| 82977 | <1% | 164 | $692.70 | |
| 88304 | <1% | 67 | $680.48 | |
| 88142 | <1% | 45 | $664.53 | |
| 72110 | <1% | 32 | $662.61 | |
| 87070 | <1% | 503 | $662.49 | |
| 74019 | <1% | 64 | $640.90 | |
| 86708 | <1% | 76 | $605.80 | |
| 0154A | <1% | 15 | $560.00 | |
| 0112A | <1% | 14 | $560.00 | |
| 76882 | <1% | 31 | $553.47 | |
| 90686 | <1% | 3,118 | $539.40 | |
| 88313 | <1% | 77 | $517.49 | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 13 | $495.84 |
| 99383 | <1% | 16 | $491.87 | |
| 86780 | <1% | 466 | $481.40 | |
| 72050 | <1% | 12 | $474.57 | |
| 88348 | <1% | 27 | $473.88 | |
| 88312 | <1% | 12 | $470.77 | |
| 93880 | <1% | 12 | $456.46 | |
| 77080 | <1% | 39 | $432.60 | |
| 93971 | <1% | 43 | $429.80 | |
| 51741 | <1% | 80 | $399.16 | |
| 71271 | <1% | 12 | $373.76 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 129 | $369.13 |
| 86255 | <1% | 77 | $321.58 | |
| 0012A | <1% | 160 | $316.97 | |
| 83655 | <1% | 27 | $304.20 | |
| 92020 | <1% | 24 | $301.32 | |
| 73070 | <1% | 55 | $294.69 | |
| 84165 | <1% | 145 | $279.76 | |
| 95251 | <1% | 12 | $272.61 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 215 | $271.72 |
| 99417 | Prolong home eval add 15m | <1% | 17 | $265.94 |
| 88346 | <1% | 29 | $258.35 | |
| 99442 | <1% | 34 | $251.81 | |
| 93923 | <1% | 33 | $243.34 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 233 | $230.17 |
| 93926 | <1% | 13 | $210.39 | |
| 0011A | <1% | 145 | $203.03 | |
| 90670 | <1% | 2,055 | $201.89 | |
| 86706 | <1% | 30 | $183.32 | |
| 80069 | <1% | 96 | $178.75 | |
| 86317 | <1% | 12 | $162.50 | |
| 0003A | <1% | 31 | $160.00 | |
| 84702 | <1% | 26 | $149.28 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 146 | $139.06 |
| 86256 | <1% | 41 | $123.23 | |
| 99443 | <1% | 27 | $118.89 | |
| 95115 | <1% | 16 | $118.31 | |
| 72040 | <1% | 13 | $117.55 | |
| 90473 | <1% | 13 | $105.44 | |
| 95012 | <1% | 12 | $100.08 | |
| 98960 | <1% | 14 | $95.08 | |
| 96158 | <1% | 14 | $93.23 | |
| 82247 | <1% | 256 | $84.89 | |
| 95970 | <1% | 13 | $83.83 | |
| 73060 | <1% | 15 | $83.26 | |
| 93990 | <1% | 81 | $76.07 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 12 | $75.00 |
| 0064A | <1% | 16 | $40.00 | |
| 86900 | <1% | 32 | $32.03 | |
| 86901 | <1% | 32 | $32.03 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 91 | $28.75 |
| 84484 | <1% | 12 | $24.08 | |
| 86140 | <1% | 18 | $21.90 | |
| 82962 | <1% | 741 | $11.11 | |
| 86762 | <1% | 13 | $9.87 | |
| 82570 | <1% | 33 | $9.79 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 32 | $2.56 |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | <1% | 25 | $0.89 |
| 91300 | <1% | 6,271 | $0.05 | |
| 90677 | <1% | 270 | $0.05 | |
| 90715 | <1% | 72 | $0.03 | |
| 91301 | <1% | 159 | $0.02 | |
| 3078F | 0% | 13,741 | $0.00 | |
| 90710 | 0% | 358 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 258 | $0.00 |
| 3077F | 0% | 233 | $0.00 | |
| 90672 | 0% | 182 | $0.00 | |
| 90648 | 0% | 1,171 | $0.00 | |
| 90633 | 0% | 975 | $0.00 | |
| 90707 | 0% | 243 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 17 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 37 | $0.00 |
| 91312 | 0% | 43 | $0.00 | |
| 90734 | 0% | 124 | $0.00 | |
| 91311 | 0% | 62 | $0.00 | |
| 3046F | 0% | 27 | $0.00 | |
| 99173 | 0% | 14 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 29 | $0.00 |
| 92552 | 0% | 14 | $0.00 | |
| 1036F | 0% | 17,656 | $0.00 | |
| 1000F | 0% | 19,068 | $0.00 | |
| 3008F | 0% | 22,190 | $0.00 | |
| 3351F | 0% | 547 | $0.00 | |
| 3074F | 0% | 10,638 | $0.00 | |
| 90680 | 0% | 1,061 | $0.00 | |
| 90698 | 0% | 637 | $0.00 | |
| 3044F | 0% | 8,229 | $0.00 | |
| 1034F | 0% | 785 | $0.00 | |
| 3079F | 0% | 628 | $0.00 | |
| 90696 | 0% | 266 | $0.00 | |
| 1220F | 0% | 152 | $0.00 | |
| 90723 | 0% | 1,083 | $0.00 | |
| 3075F | 0% | 965 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 41 | $0.00 |
| 90651 | 0% | 388 | $0.00 | |
| 90716 | 0% | 216 | $0.00 | |
| 91307 | 0% | 684 | $0.00 | |
| 91315 | 0% | 15 | $0.00 | |
| 90619 | 0% | 80 | $0.00 | |
| 90688 | 0% | 56 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 14 | $0.00 |
| 86880 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARKS, ANDREA (VICE PRESIDENT FOR BUSINESS AFFAIRS)
| Provider | Location | Paid |
|---|---|---|
| Ut Dentistry San Antonio | San Antonio, TX | $175K |
| Ricardo Salinas Clinic | San Antonio, TX | $134K |
| University of Texas Health Science Center at San Antonio | San Antonio, TX | $13K |
| University of Texas Health Science Center at San Antonio | Boerne, TX | $128.52 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.